Final results from the phase 3 VALOR trial and open-label extension evaluating efficacy and safety of tofersen in adults with SOD1-ALS

Miller, T.M., Cudkowicz, M.E., Shaw, P.J. orcid.org/0000-0002-8925-2567 et al. (9 more authors) (2025) Final results from the phase 3 VALOR trial and open-label extension evaluating efficacy and safety of tofersen in adults with SOD1-ALS. In: Muscle & Nerve. 24th Annual Meeting of the Northeast ALS Consortium, 07-10 Oct 2025, Florida, USA. , S97-S97. ISSN: 0148-639X. EISSN: 1097-4598.